US Stock MarketDetailed Quotes

NMRA Neumora Therapeutics

Watchlist
  • 18.570
  • +0.030+0.16%
Close 02/27 16:00 ET
2.84BMarket Cap-18259P/E (TTM)

About Neumora Therapeutics Company

Neumora Therapeutics, Inc. is a clinical-stage biotechnology company. It offers a precision medicine approach for brain diseases through the integration of data science and neuroscience. The firm focuses on advancing medicines for therapeutically relevant targets implicated in CNS diseases, targeting novel mechanisms of action with best-in-class pharmacology. The company was founded by Paul L. Berns, Carol Suh and Mike Poole in November 2019 and is headquartered in Watertown, MA.

Company Profile

SymbolNMRA
Company NameNeumora Therapeutics
Listing Date09/15/2023
Issue Price17.00
Founded2019
CEOMr. Henry O. Gosebruch
MarketNASDAQ
Employees110
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address490 Arsenal Way,Suite 200
CityWatertown
ProvinceMassachusetts
CountryUnited States of America
Zip Code02472

Company Executives

  • Name
  • Position
  • Salary
  • Henry O. Gosebruch
  • Director, President and Chief Executive Officer
  • --
  • Dr. Michael Gold, M.D.,M.S.
  • Chief Medical Officer
  • --
  • Dr. Daljit Singh Aurora, Pharm.D.
  • Chief Development Officer
  • --
  • Dr. Joshua Pinto, PhD
  • Chief Financial Officer
  • 3.82M
  • Carol Suh
  • Chief Operating Officer
  • --
  • Dr. Nicholas Brandon, PhD
  • Chief Scientific Officer
  • --
  • Dr. Maryjo Chamberlain-Tharp, PhD
  • Chief Business Officer
  • --
  • Lori Houle
  • Chief Quality Officer
  • --
  • Dr. Raj Manchanda, PhD
  • Chief Technical Operations Officer
  • --
  • Michael Milligan
  • Principal Accounting Officer
  • --
  • Paul L. Berns
  • Executive Chairman of the Board
  • 2.63M
  • Dr. Kari Stefansson,M.D.
  • Independent Director
  • --
  • Matthew K. Fust
  • Independent Director
  • 40.00K
  • Robert Taylor Nelsen
  • Independent Director
  • --
  • Kristina M. Burow
  • Independent Director
  • --
  • Dr. Maykin Ho, PhD
  • Independent Director
  • 40.00K
  • Alaa Halawa
  • Independent Director
  • --
  • Dr. Robert Lenz, M.D.
  • Head of Research and Development
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg